Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right per 2025 Jun 30 adalah 984.27 MM.
- Nilai operating income untuk JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right per 2025 Jun 30 adalah 132.50 MM.
- Nilai net income untuk JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right per 2025 Jun 30 adalah 28.43 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-06-30 | 984.27 | 132.50 | 28.43 |
| 2025-03-31 | 918.42 | 116.01 | 14.48 |
| 2024-12-31 | 845.93 | 102.35 | 4.52 |
| 2024-09-30 | 769.05 | 81.10 | 51.16 |
| 2024-06-30 | 702.51 | 37.65 | 21.50 |
| 2024-03-31 | 627.73 | -0.10 | -6.04 |
| 2023-12-31 | 594.36 | -0.41 | -1.72 |
| 2023-09-30 | 585.42 | 12.94 | 2.49 |
| 2023-06-30 | 518.35 | 4.59 | -5.56 |
| 2023-03-31 | 505.58 | 12.15 | -4.04 |
| 2022-12-31 | 466.80 | -1.07 | -17.48 |
| 2022-09-30 | 419.14 | -15.75 | -24.14 |
| 2022-06-30 | 418.64 | 0.28 | -13.11 |
| 2022-03-31 | 418.84 | 23.74 | 10.63 |
| 2021-12-31 | 429.13 | 48.30 | 29.69 |
| 2021-09-30 | 422.41 | 52.64 | 32.05 |
| 2021-06-30 | 421.18 | 53.04 | 31.85 |
| 2021-03-31 | 432.95 | 50.15 | 29.26 |
| 2020-12-31 | 462.74 | 53.12 | 31.08 |
Laporan Laba Rugi: EPS
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | 0.01 | 0.01 |
| 2024-09-30 | 0.11 | 0.11 |
| 2024-06-30 | 0.05 | 0.04 |
| 2024-03-31 | -0.01 | -0.01 |
| 2023-12-31 | -0.00 | |
| 2023-09-30 | 0.01 | 0.00 |
| 2023-06-30 | -0.01 | -0.02 |
| 2023-03-31 | -0.01 | -0.01 |
| 2022-12-31 | -0.04 | -0.04 |
| 2022-09-30 | -0.05 | -0.06 |
| 2022-06-30 | -0.03 | -0.03 |
| 2022-03-31 | 0.03 | 0.02 |
| 2021-12-31 | 0.08 | 0.08 |
| 2021-09-30 | 0.09 | 0.10 |
| 2021-06-30 | 0.10 | 0.10 |
| 2021-03-31 | 0.08 | 0.08 |
| 2020-12-31 | 0.09 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right per 2025 Jun 30 adalah 127.54 MM.
- Nilai cash from investing activities untuk JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right per 2025 Jun 30 adalah -43.84 MM.
- Nilai kas dari aktivitas pendanaan untuk JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right per 2025 Jun 30 adalah -78.90 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-06-30 | 127.54 | -43.84 | -78.90 |
| 2025-03-31 | 132.93 | -46.13 | -84.80 |
| 2024-12-31 | 132.12 | -56.64 | -66.64 |
| 2024-09-30 | 118.32 | -74.02 | -32.22 |
| 2024-06-30 | 77.13 | -132.81 | 21.33 |
| 2024-03-31 | 44.35 | -152.02 | 20.43 |
| 2023-12-31 | 40.35 | -202.49 | 82.60 |
| 2023-09-30 | 39.03 | -139.68 | 73.99 |
| 2023-06-30 | 49.00 | -136.57 | 14.79 |
| 2023-03-31 | 68.62 | -330.99 | 21.72 |
| 2022-12-31 | 2.81 | -463.90 | -64.61 |
| 2022-09-30 | -17.71 | -543.38 | 616.92 |
| 2022-06-30 | -19.55 | -472.58 | 629.46 |
| 2022-03-31 | -1.62 | -253.84 | 615.17 |
| 2021-12-31 | 51.72 | -58.26 | 629.95 |
| 2021-09-30 | 77.99 | -14.19 | -58.21 |
| 2021-06-30 | 61.50 | -10.71 | -53.78 |
| 2021-03-31 | 46.83 | -6.91 | -41.11 |
| 2020-12-31 | 45.99 | -1.53 | -44.10 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-06-30 | |||
| 2025-03-31 | |||
| 2024-12-31 | |||
| 2024-09-30 | |||
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | |||
| 2023-06-30 | |||
| 2023-03-31 | |||
| 2022-12-31 | |||
| 2022-09-30 | |||
| 2022-06-30 | |||
| 2022-03-31 | |||
| 2021-12-31 | |||
| 2021-09-30 | |||
| 2021-06-30 | |||
| 2021-03-31 | |||
| 2020-12-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | ||
| 2024-09-30 | ||
| 2024-06-30 | ||
| 2024-03-31 | ||
| 2023-12-31 | ||
| 2023-09-30 | ||
| 2023-06-30 | ||
| 2023-03-31 | ||
| 2022-12-31 | ||
| 2022-09-30 | ||
| 2022-06-30 | ||
| 2022-03-31 | ||
| 2021-12-31 | ||
| 2021-09-30 | ||
| 2021-06-30 | ||
| 2021-03-31 | ||
| 2020-12-31 |
Efektivitas Manajemen
- roa untuk JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right pada 2025 Jun 30 adalah -0.00.
- roe untuk JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right pada 2025 Jun 30 adalah -0.00.
- roic untuk JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right pada 2025 Jun 30 adalah -0.00.
- croic untuk JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right pada 2025 Jun 30 adalah -0.07.
- ocroic untuk JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right pada 2025 Jun 30 adalah 0.03.
| Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
| 2025-06-30 | -0.00 | -0.00 | -0.00 | -0.07 | 0.03 |
| 2025-03-31 | -0.00 | -0.00 | -0.00 | -0.07 | 0.03 |
| 2024-12-31 | -0.00 | -0.00 | -0.00 | -0.07 | 0.03 |
| 2024-09-30 | -0.00 | -0.00 | -0.00 | -0.07 | 0.03 |
| 2024-06-30 | -0.00 | -0.00 | -0.00 | -0.07 | 0.03 |
| 2024-03-31 | -0.00 | -0.00 | -0.00 | -0.07 | 0.03 |
| 2023-12-31 | 0.00 | 0.00 | 0.00 | -0.02 | 0.03 |
| 2023-09-30 | -0.00 | -0.01 | -0.00 | -0.06 | 0.03 |
| 2023-06-30 | -0.00 | -0.01 | -0.00 | -0.06 | 0.03 |
| 2023-03-31 | -0.00 | -0.00 | -0.00 | -0.21 | 0.05 |
| 2022-12-31 | -0.04 | -0.13 | -0.02 | 0.05 | -0.02 |
| 2022-09-30 | -0.04 | -0.13 | -0.02 | 0.05 | -0.02 |
| 2022-06-30 | -0.02 | -0.06 | -0.01 | 0.12 | -0.02 |
| 2022-03-31 | 0.02 | 0.05 | 0.01 | 0.32 | -0.00 |
| 2021-12-31 | 0.06 | 0.15 | 0.02 | 0.52 | 0.04 |
| 2021-09-30 | 0.19 | 0.07 | 0.01 | 0.17 | |
| 2021-06-30 | 0.07 | 0.19 | 0.07 | -0.01 | 0.13 |
| 2021-03-31 | 0.07 | 0.18 | 0.07 | -0.00 | 0.12 |
| 2020-12-31 | 0.07 | 0.19 | 0.08 | 0.00 | 0.11 |
Gross Margins
- marjin kotor untuk JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right pada 2025 Jun 30 adalah 0.27.
- marjin bersih untuk JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right pada 2025 Jun 30 adalah -0.00.
- marjin operasi untuk JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right pada 2025 Jun 30 adalah 0.00.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
| Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
| 2025-06-30 | 0.27 | -0.00 | 0.00 |
| 2025-03-31 | 0.27 | -0.00 | 0.00 |
| 2024-12-31 | 0.27 | -0.00 | 0.00 |
| 2024-09-30 | 0.27 | -0.00 | 0.00 |
| 2024-06-30 | 0.27 | -0.00 | 0.00 |
| 2024-03-31 | 0.27 | -0.00 | 0.00 |
| 2023-12-31 | 0.26 | 0.00 | -0.00 |
| 2023-09-30 | 0.28 | -0.01 | 0.00 |
| 2023-06-30 | 0.28 | -0.01 | 0.00 |
| 2023-03-31 | 0.30 | -0.01 | 0.00 |
| 2022-12-31 | 0.30 | -0.06 | -0.06 |
| 2022-09-30 | 0.30 | -0.06 | -0.06 |
| 2022-06-30 | 0.31 | -0.03 | -0.02 |
| 2022-03-31 | 0.34 | 0.03 | 0.06 |
| 2021-12-31 | 0.35 | 0.07 | 0.11 |
| 2021-09-30 | 0.35 | 0.08 | 0.12 |
| 2021-06-30 | 0.35 | 0.08 | 0.13 |
| 2021-03-31 | 0.34 | 0.07 | 0.12 |
| 2020-12-31 | 0.33 | 0.07 | 0.11 |
Pengenal dan Deskriptor
| Kunci Indeks Pusat (CIK) |
